Conexeu director holds options for 50K shares

Conexeu Sciences Inc. director Burke April Lynn reported holdings of stock options rather than a new trade.

Rhea-AI Filing Summary

Conexeu Sciences Inc. director Burke April Lynn reported holdings of stock options rather than a new trade. She holds options to buy 50,000 shares of common stock at an exercise price of $2.30 per share, expiring on February 9, 2031. These options were granted on February 9, 2026 and vest in four equal 25% installments over a 12‑month period.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Burke April Lynn

Role Director

Type	Security	Shares	Price	Value
holding	Option (right to buy)	--	--	--

Holdings After Transaction: Option (right to buy) — 50,000 contracts (Direct)

Footnotes (1)

1. F1. Represents options to purchase shares of common stock that were granted on February 9, 2026 and vest over a 12-month period (25% three, six, nine and twelve months from the date of grant).

Key Figures

Underlying shares: 50,000 shares Exercise price: $2.30 per share Expiration date: February 9, 2031 +1 more

4 metrics

Underlying shares 50,000 shares Underlying common stock covered by options

Exercise price $2.30 per share Option exercise price for Conexeu common stock

Expiration date February 9, 2031 Option grant expiry

Vesting schedule 25% at 3, 6, 9, 12 months From February 9, 2026 grant date over 12 months

Key Terms

Option (right to buy), underlying security, exercise price, expiration date, +1 more

5 terms

Option (right to buy) financial

"security_title: Option (right to buy)"

underlying security financial

"underlying_security_title: Common Stock"

exercise price financial

"conversion_or_exercise_price: 2.3000"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

expiration date financial

"expiration_date: 2031-02-09T00:00:00.000Z"

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

vest over a 12-month period financial

"were granted on February 9, 2026 and vest over a 12-month period"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Conexeu Sciences (CNXU) director Burke April Lynn report on this Form 3?

Burke April Lynn reported her existing holdings of stock options, not a new trade. She holds options to purchase 50,000 Conexeu Sciences common shares, disclosed as part of her initial insider ownership statement.

How many Conexeu Sciences (CNXU) shares are covered by Burke April Lynn’s options?

Her options cover 50,000 underlying shares of Conexeu Sciences common stock. This figure reflects the total number of shares she may acquire through these options if they fully vest and are exercised according to their terms.

What is the exercise price of Burke April Lynn’s Conexeu Sciences (CNXU) options?

The options have an exercise price of $2.30 per share. This is the fixed price at which she can purchase Conexeu Sciences common stock when the options vest and before they expire, if she chooses to exercise them.

When do Burke April Lynn’s Conexeu Sciences (CNXU) options vest?

The options vest over a 12‑month period from the February 9, 2026 grant date. Vesting occurs in four equal 25% installments at three, six, nine, and twelve months following the date the options were granted.

When do Burke April Lynn’s Conexeu Sciences (CNXU) options expire?

The options expire on February 9, 2031. After this expiration date, any unexercised portion of the options will lapse, and she would no longer be able to buy Conexeu Sciences shares under this specific grant.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/24/2026 - 04:15 PM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Burke April Lynn

(Last) (First) (Middle)

50 WEST LIBERTY STREET, SUITE 880

(Street)

RENO NEVADA 89501

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
06/15/2026

3. Issuer Name and Ticker or Trading Symbol
Conexeu Sciences Inc. [ CNXU ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option (right to buy)	(1)	02/09/2031	Common Stock	50,000	$2.3	D

Explanation of Responses:

1. Represents options to purchase shares of common stock that were granted on February 9, 2026 and vest over a 12-month period (25% three, six, nine and twelve months from the date of grant).

	/s/ April Burke	06/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)